Skip Navigation



ICC Advance Access published online on April 20, 2006
Industrial and Corporate Change, doi:10.1093/icc/dtl007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
15/4/625    most recent
dtl007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nesta, L.
Right arrow Articles by Saviotti, P.-P.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of Associazione ICC. All rights reserved.

Article

Firm knowledge and market value in biotechnology

Lionel Nesta 1 * and Pier-Paolo Saviotti 2

1 Lionel Nesta, Observatoire Français des Conjonctures Economiques, Département de Recherche sur l’Innovation et la Concurrence, OFCE - DRIC, 250, rue Albert Einstein -06560, Valbonne, France
2 Pier-Paolo Saviotti, UMR GAEL, Université Pierre Mendès-France, BP47, 38040 Grenoble Cedex, France

* To whom correspondence should be addressed.
Lionel Nesta, E-mail: nesta{at}idefi.cnrs.fr


  Abstract

We examine the relationship between the characteristics of the firms’ knowledge base in terms of knowledge capital and knowledge integration and the stock market value of 84 firms active in biotechnology during the 1990s. Panel data regression models show that the degree of knowledge integration within firms is a significant explanatory variable of firms’ stock market value. Moreover, knowledge integration becomes an increasingly important determinant of market value, which illustrates the growing integration of biotechnology in several industrial applications. However, the role of knowledge is sector specific, revealing differences in the extent to which biotechnology has become a key technology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ind Corp ChangeHome page
D. Peirone
Knowledge and venture funding: complementarities and financial contracts
Ind. Corp. Change, October 1, 2007; 16(5): 851 - 873.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.